Tara L. Reinhart

Ms. Reinhart is the former chief trial counsel for the Federal Trade Commission Bureau of Competition. While there, she led a trial team to victory in the FTC’s challenge to Staples’ proposed acquisition of Office Depot, among several other proceedings. Since returning to Skadden, Ms. Reinhart has led trial teams in two Department of Justice Antitrust Division merger challenges, including a win on behalf of Sabre Corporation in 2020. In 2022, Ms. Reinhart again successfully represented Sabre in a three-week jury trial victory in an action brought by US Airways alleging violations of Sections 1 and 2 of the Sherman Act, with a jury finding Sabre not liable on one claim and awarding $1 in damages on the other. In January 2023, on the eve of trial, Ms. Reinhart obtained dismissal of all federal antitrust claims brought against Norfolk Southern Railway Company in a lawsuit by CSX Transportation.

In private practice in the government investigations area, Ms. Reinhart has handled criminal and civil investigations by the Department of Justice’s Antitrust Division, the FTC and state attorneys general in many industries. She represents companies and individuals in FTC investigations into alleged violations of Section 5(a) of the FTC Act for unfair advertising and marketing practices, such as allegations of deceptive online advertising, negative option marketing and multi-level marketing. Ms. Reinhart has handled criminal antitrust investigations for companies and individuals in pharmaceuticals, auto parts, freight forwarding, marine hose, air cargo, helicopter transportation, industrial chemicals, methionine, vitamins, graphite electrodes, flavorants and stay cable bridges industries.

In the litigation area, Ms. Reinhart has handled many class actions alleging price-fixing for companies such as Anheuser Busch, Hankyu Hanshin Express, Norfolk Southern Railway Company, Southeastern Freight Lines, Korean Air Lines, Degussa and others. She has handled a number of private actions alleging monopolization and conspiracy to monopolize, including claims of reverse payments agreements for pharmaceutical companies.

Ms. Reinhart has been selected for inclusion repeatedly in Chambers USA, in which clients noted that she is “very talented at working through issues strategically and tactically,” and as one of Lawdragon’s 500 Leading Litigators in America. In addition, she was named a finalist for Global Competition Review’s 2023 Litigator of the Year award and selected to GCR’s 2021 Women in Antitrust list.